Search the GHTC website
March 2024

Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World

Examines the blockbuster returns from US government investment in global health R&D, including the lifesaving tools advanced and the economic and health benefits generated globally and domestically.

March 2024

Across the US: Learn how global health R&D delivers across the United States

Interactive online tool and individualized state fact sheets documenting how US investments in global health R&D are delivering economic and health benefits across American states.

March 2023

US agency series: Global health R&D across the US government

This six-part fact sheet series examines the contributions of US government agencies to advancing global health R&D. The series includes the US Agency for International Development, National Institutes of Health, Centers for Disease Control and Prevention, Biomedical Advanced Research and Development Authority, Department of Defense, and Food and Drug Administration.

January 2023

Recommendations for the Pandemic and All-Hazards Preparedness Act (PAHPA) of 2023

Ahead of the 2023 reauthorization of the Biomedical Advanced Research and Development Authority (BARDA), the Pandemic and All Hazards Preparedness Act (PAHPA) 2023 policy memo outlines GHTC’s priorities for the reauthorization of BARDA. 

Stay updated

Find out about GHTC’s membership options and the benefits of becoming a member.

Learn More